HYAL-CT1101 3 percent diclofenac gel data

HYALF said that in a Phase III trial in 108 patients, 47 percent of those using the gel had a clinical cure of all lesions by the end of the study, compared to 19 percent on placebo (p<0.001). Those taking drug had a 79 percent decrease in number of lesions versus a 60 percent decrease in the placebo group (p<0.001). ...